Related Experiment Video
Updated: Sep 3, 2025
10:13
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.4K
Adapting methadone inductions to the fentanyl era
Megan Buresh1, Shadi Nahvi2, Scott Steiger3
1Division of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States of America; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
Journal of Substance Abuse Treatment
|July 23, 2022
Summary
The rise of potent fentanyl analogs necessitates adapting methadone dosing protocols in opioid treatment programs (OTPs). Faster methadone induction schedules are needed to effectively manage opioid use disorder in the current drug supply era.
Area of Science:
- Addiction Medicine
- Pharmacology
- Public Health
Background:
- Fentanyl and its analogs, significantly more potent than heroin, have dominated the illicit opioid supply since 2013.
- Current methadone dosing protocols in US opioid treatment programs (OTPs) are often conservative, based on pre-fentanyl expert consensus.
- Existing OTP reforms primarily focus on take-home medication access, neglecting induction schedule optimization.
Discussion:
- Adapting methadone induction schedules is crucial for effective opioid use disorder (OUD) treatment in the fentanyl era.
- Emerging evidence and real-world experiences suggest that more aggressive methadone induction protocols can be beneficial.
- Physician expertise across the US highlights the need for updated approaches to methadone treatment.
Key Insights:
- The current methadone induction framework requires urgent revision to address the challenges posed by fentanyl analogs.
- Opioid treatment programs (OTPs) are exploring and implementing more rapid methadone induction strategies.
- A shift towards evidence-based, aggressive induction protocols is supported by clinical experience.
Outlook:
- Further research is essential to establish safety and best practices for accelerated methadone induction.
- Updated clinical guidelines are needed to support OTPs in adapting to the fentanyl landscape.
- Optimizing methadone induction is key to improving treatment outcomes for individuals with OUD.
More Related Videos
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
412
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
412
01:25Analgesia and Pain Management
779
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
779
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
352
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
352
01:24Parenteral Anesthetics: Overview
191
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
191
01:15Drug Abuse and Addiction: Pharmacological Phenomena
641
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
641
01:20Desensitization and Tachyphylaxis
2.1K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.1K